Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Monolithic shape-programmable dielectric liquid crystal elastomer actuators.

Davidson ZS, Shahsavan H, Aghakhani A, Guo Y, Hines L, Xia Y, Yang S, Sitti M.

Sci Adv. 2019 Nov 22;5(11):eaay0855. doi: 10.1126/sciadv.aay0855. eCollection 2019 Nov.

2.

Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients.

Bavand A, Aghakhani A, Mohraz M, Banifazl M, Karami A, Golkar M, Babaie J, Saleh P, Mamishi S, Ramezani A.

Iran J Pathol. 2019 Winter;14(1):68-75. doi: 10.30699/IJP.14.1.68. Epub 2018 Dec 27.

3.

Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population.

Ramezani A, Baesi K, Banifazl M, Mohraz M, Khorvash F, Yaran M, Tabarsi P, Dalirrooyfard AH, Motevalli F, Bavand A, Aghakhani A.

Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):594-602. doi: 10.1016/j.clinre.2019.01.011. Epub 2019 May 10.

PMID:
31080115
4.

Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women.

Ramezani A, Aghakhani A, Soleymani S, Bavand A, Bolhassani A.

BMC Infect Dis. 2019 Feb 12;19(1):142. doi: 10.1186/s12879-019-3780-2.

5.

HapTable: An Interactive Tabletop Providing Online Haptic Feedback for Touch Gestures.

Emgin SE, Aghakhani A, Sezgin TM, Basdogan C.

IEEE Trans Vis Comput Graph. 2019 Sep;25(9):2749-2762. doi: 10.1109/TVCG.2018.2855154. Epub 2018 Jul 11.

PMID:
30004878
6.

Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.

Zadsar M, Aghakhani A, Banifazl M, Kazemimanesh M, Tabatabaei Yazdi SM, Mamishi S, Bavand A, Sadat Larijani M, Ramezani A.

J Med Virol. 2018 Aug;90(8):1318-1322. doi: 10.1002/jmv.25195. Epub 2018 May 1.

PMID:
29663448
7.

Intra-familial Transmission of Hepatitis B Virus Infection in Arak, Central Iran.

Sofian M, Banifazl M, Ziai M, Aghakhani A, Farazi AA, Ramezani A.

Iran J Pathol. 2016 Fall;11(4):328-333.

8.

No Role of Herpes Simplex Virus Type 2 (HSV-2) Infection on HIV Progression in Naïve HIV Patients

Mohraz M, Aghakhani A, Moayedi-Nia S, Banifazl M, Janbakhsh A, Mamishi S, Karami A, Bavand A, Mirzapour P, Ramezani A.

Iran Biomed J. 2018 Mar;22(2):123-8. Epub 2017 Jul 9.

9.

Distribution of hepatitis C virus genotypes in Arak city, central province of Iran.

Sofian M, Ramezani A, Imani H, Farazi AA, Banifazl M, Jourabchi A, Aghakhani A.

Iran J Microbiol. 2016 Oct;8(5):321-325.

10.

Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.

Sharif A, Aghakhani A, Velayati AA, Banifazl M, Sharif MR, Razeghi E, Kheirkhah D, Kazemimanesh M, Bavand A, Ramezani A.

Intervirology. 2016;59(3):179-185. doi: 10.1159/000455124. Epub 2017 Feb 1.

11.

Interlukine-17 and TGF-β levels in patients with acute brucellosisbefore and after treatment.

Sofian M, Ramezani A, Mousavi A, Banifazl M, Cherei S, Cherei A, Aghakhani A.

Turk J Med Sci. 2016 Nov 17;46(5):1348-1352. doi: 10.3906/sag-1506-59.

PMID:
27966296
12.

Gender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.

Aghakhani A, Mamishi S, Sabeti S, Bidari-Zerehpoosh F, Banifazl M, Bavand A, Ramezani A.

Med Microbiol Immunol. 2017 Apr;206(2):105-110. doi: 10.1007/s00430-016-0487-5. Epub 2016 Nov 17.

PMID:
27858157
13.

BK Viremia among Iranian Renal Transplant Candidates.

Jozpanahi M, Ramezani A, Ossareh S, Banifazl M, Bavand A, Mamishi S, Aghakhani A.

Iran J Pathol. 2016 Summer;11(3):210-215.

14.

Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.

Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.

Arch Virol. 2016 Dec;161(12):3405-3411. Epub 2016 Sep 9.

PMID:
27613286
15.

No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV.

Ramezani A, Saboori E, Azadmanesh K, Mohraz M, Kazemimanesh M, Karami A, Banifazl M, Golchehregan H, Aghakhani A.

Iran J Public Health. 2016 Jul;45(7):935-40.

16.

Fast Quantitation of Target Analytes in Small Volumes of Complex Samples by Matrix-Compatible Solid-Phase Microextraction Devices.

Piri-Moghadam H, Ahmadi F, Gómez-Ríos GA, Boyacı E, Reyes-Garcés N, Aghakhani A, Bojko B, Pawliszyn J.

Angew Chem Int Ed Engl. 2016 Jun 20;55(26):7510-4. doi: 10.1002/anie.201601476. Epub 2016 May 9.

PMID:
27158909
17.

No evidence of persistent parvovirus B19 viremia among Iranian patients with HIV after a 1-year follow-up.

Aghakhani A, Mohraz M, Azadmanesh K, Moayedi-Nia S, Kazemimanesh M, Mamishi S, Banifazl M, Ramezani A.

Arch Virol. 2016 May;161(5):1183-7. doi: 10.1007/s00705-016-2782-2. Epub 2016 Feb 10.

PMID:
26860911
18.

Assessment of the Association between Human Papillomavirus Infection and Breast Carcinoma.

Eslamifar A, Ramezani A, Azadmanesh K, Bidari-Zerehpoosh F, Banifazl M, Aghakhani A.

Iran J Pathol. 2015 Winter;10(1):41-6.

19.

Occult hepatitis C virus infection in Iranian hemodialysis patients.

Eslamifar A, Ramezani A, Ehteram H, Razeghi E, Ahmadi F, Amini M, Banifazl M, Etemadi G, Keyvani H, Bavand A, Aghakhani A.

J Nephropathol. 2015 Oct;4(4):116-20. doi: 10.12860/jnp.2015.22. Epub 2015 Oct 1.

20.

Occult hepatitis B virus infection and S gene escape mutants in HIV-infected patients after hepatitis B virus vaccination.

Aghakhani A, Mohraz M, Aghasadeghi MR, Banifazl M, Vahabpour R, Karami A, Foroughi M, Ramezani A.

Int J STD AIDS. 2016 Oct;27(11):967-72. doi: 10.1177/0956462415602419. Epub 2015 Sep 18.

PMID:
26384943
21.

Lack of Association between Interleukin-10 Gene Promoter Polymorphisms with HIV Susceptibility and Progression to AIDS.

Ramezani A, Kalantar E, Aghakhani A, Banifazl M, Foroughi M, Hosseini S, Eslamifar A, Esmaeilzadeh A, Mohraz M.

Iran J Pathol. 2015 Spring;10(2):141-8.

22.

Frequency and subtype of BK virus infection in Iranian patients infected with HIV.

Akhgari S, Mohraz M, Azadmanesh K, Vahabpour R, Kazemimanesh M, Aghakhani A, Jozpanahi M, Banifazl M, Bavand A, Ramezani A.

Med Microbiol Immunol. 2016 Feb;205(1):57-62. doi: 10.1007/s00430-015-0426-x. Epub 2015 Jul 4.

PMID:
26141042
23.

Immunity to diphtheria and tetanus among blood donors in Arak, central province of Iran.

Eslamifar A, Ramezani A, Banifazl M, Sofian M, Mahdaviani FA, Yaghmaie F, Aghakhani A.

Iran J Microbiol. 2014 Jun;6(3):190-3.

24.

No evidence for occult HBV infection in hepatitis B vaccine non-responders.

Aghasadeghi MR, Banifazl M, Aghakhani A, Eslamifar A, Vahabpour R, Ramezani A.

Iran J Microbiol. 2014 Oct;6(5):350-3.

25.

Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.

Azadmanesh K, Mohraz M, Kazemimanesh M, Aghakhani A, Foroughi M, Banifazl M, Eslamifar A, Ramezani A.

J Med Virol. 2015 Jul;87(7):1124-9. doi: 10.1002/jmv.24169. Epub 2015 Mar 13.

PMID:
25771750
26.

Prevalence of BK viremia in Iranian hemodialysis and peritoneal dialysis patients.

Sharif A, Sharif MR, Aghakhani A, Banifazl M, Hamkar R, Ghavami N, Eslamifar A, Ramezani A.

Infect Dis (Lond). 2015 May;47(5):345-8. doi: 10.3109/00365548.2014.1002107. Epub 2015 Mar 6.

PMID:
25746602
27.

Isolated anti-hbc and occult HBV infection in dialysis patients.

Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A.

Nephrourol Mon. 2014 Nov 30;7(1):e22674. doi: 10.5812/numonthly.22674. eCollection 2015 Jan.

28.

Lack of human papillomavirus DNA in colon adenocarcinama and adenoma.

Aghakhani A, Hamkar R, Ramezani A, Bidari-Zerehpoosh F, Sabeti S, Ghavami N, Banifazl M, Rashidi N, Eslamifar A.

J Cancer Res Ther. 2014 Jul-Sep;10(3):531-4. doi: 10.4103/0973-1482.137674.

29.

Serological response to one intradermal or intramuscular hepatitis B virus vaccine booster dose in human immunodeficiency virus-infected nonresponders to standard vaccination.

Ramezani A, Janbakhsh A, Gol-Mohammadi M, Banifazl M, Aghakhani A, Eslamifar A, Pournasiri Z, Mahdavian B, Farazi AA, Sofian M.

Perspect Clin Res. 2014 Jul;5(3):134-8. doi: 10.4103/2229-3485.134318.

30.

Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.

Sofian M, Velayati AA, Aghakhani A, McFarland W, Farazi AA, Banifazl M, Eslamifar A, Ramezani A.

Scand J Infect Dis. 2014 Aug;46(8):573-7. doi: 10.3109/00365548.2014.918275. Epub 2014 Jun 16.

PMID:
24934986
31.

Rapid analysis of Origanum majorana L. fragrance using a nanofiber sheet, gas chromatography with mass spectrometry, and chemometrics.

Asadollahi-Baboli M, Aghakhani A.

J Sep Sci. 2014 Apr;37(8):990-6. doi: 10.1002/jssc.201301355. Epub 2014 Mar 13.

PMID:
24520037
32.

HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.

Ramezani A, Amirmoezi R, Volk JE, Aghakhani A, Zarinfar N, McFarland W, Banifazl M, Mostafavi E, Eslamifar A, Sofian M.

AIDS Care. 2014;26(9):1122-6. doi: 10.1080/09540121.2014.882485. Epub 2014 Feb 6.

33.

Screening of family members of patients with acute brucellosis in an endemic area of Iran.

Sofian M, Safaeipour L, Aghakhani A, Sharif MR, Banifazl M, Sharif A, Farazi AA, Eslamifar A, Didgar F, Ramezani A.

Iran J Microbiol. 2013 Sep;5(3):215-9.

34.

A highly thermal-resistant electrospun-based polyetherimide nanofibers coating for solid-phase microextraction.

Bagheri H, Akbarinejad A, Aghakhani A.

Anal Bioanal Chem. 2014 Mar;406(8):2141-9. doi: 10.1007/s00216-013-7407-y. Epub 2013 Nov 8.

PMID:
24202190
35.

Importance of isolated anti-hbc in detection of occult hepatitis B virus infection in hemodialysis patients.

Ramezani A, Eslamifar A, Banifazl M, Aghakhani A.

Ther Apher Dial. 2013 Dec;17(6):644. doi: 10.1111/1744-9987.12125. Epub 2013 Sep 12. No abstract available.

PMID:
24094234
36.

Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran.

Ramezani A, Velayati AA, Khorami-Sarvestani S, Eslamifar A, Mohraz M, Banifazl M, Bidari-Zerehpoosh F, Yaghmaei F, McFarland W, Foroughi M, Keyvani H, Mostafavi E, Aghakhani A.

Int J STD AIDS. 2013 Oct;24(10):769-74. doi: 10.1177/0956462413484457. Epub 2013 Jul 10.

PMID:
23970597
37.

No correlation between interleukin-10 gene promoter polymorphisms and hepatitis B virus infection outcome.

Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, Eslamifar A, Jourabchi A, Farazi AA, Ramezani A.

Hepat Mon. 2013 May 19;13(5):e8803. doi: 10.5812/hepatmon.8803. Print 2013 May.

38.

Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis.

Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, Foroughi M, Ahmadi F, Eslamifar A, Sadat SM, Ramezani A.

Hepat Mon. 2013 May 11;13(5):e7481. doi: 10.5812/hepatmon.7481. Print 2013 May.

39.

Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012.

Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, Aghakhani A, Mashayekhi P.

Iran J Microbiol. 2013 Jun;5(2):172-6.

40.

Outcome of hemodialysis patients with occult hepatitis B virus infection at a 4 year follow-up.

Ramezani A, Banifazl M, Eslamifar A, Ahmadi F, Razeghi E, Aghakhani A.

J Gastrointestin Liver Dis. 2013 Mar;22(1):111-2. No abstract available.

41.

Low Prevalence of Brucella agglutinins in Blood Donors in Central Province of Iran.

Sofian M, Sheikholeslami M, Mahdaviani FA, Aghakhani A, Banifazl M, Eslamifar A, Sarmadian H, Deiri G, Ramezani A.

Iran J Microbiol. 2013 Mar;5(1):24-7.

42.

Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients.

Sofian M, Aghakhani A, Farazi AA, Banifazl M, Eslamifar A, Rashidi N, Khadem Sadegh A, Ramezani A.

Hepat Mon. 2012 Dec;12(12):e6156. doi: 10.5812/hepatmon.6156. Epub 2012 Dec 29.

43.

Occult hepatitis B infection in different high risk patients.

Ramezani A, Banifazl M, Eslamifar A, Sofian M, Aghakhani A.

Hepat Mon. 2012 Jul;12(7):467-8. Epub 2012 Jul 30. No abstract available.

44.

Viral Hepatitis and HIV Infection in Hemodialysis Patients.

Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F, Ramezani A.

Hepat Mon. 2012 Jul;12(7):463-4. Epub 2012 Jul 30. No abstract available.

45.

Viral hepatitis and HIV infection among injection drug users in a central Iranian City.

Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, Eslamifar A, Ramezani A.

J Addict Med. 2012 Dec;6(4):292-6. doi: 10.1097/ADM.0b013e3182659928.

PMID:
22895463
46.

Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration.

Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A.

Ther Apher Dial. 2012 Aug;16(4):328-33. doi: 10.1111/j.1744-9987.2012.01072.x. Epub 2012 May 11. Review.

PMID:
22817120
47.

The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome.

Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A.

Hepat Mon. 2012 May;12(5):320-5. doi: 10.5812/hepatmon.6094. Epub 2012 May 30.

48.

Reprint of: Extraction of fluoxetine from aquatic and urine samples using sodium dodecyl sulfate-coated iron oxide magnetic nanoparticles followed by spectrofluorimetric determination.

Bagheri H, Zandi O, Aghakhani A.

Anal Chim Acta. 2012 Feb 24;716:61-5. doi: 10.1016/j.aca.2011.10.033. Epub 2011 Nov 19. No abstract available.

PMID:
22284879
49.

Novel polyamide-based nanofibers prepared by electrospinning technique for headspace solid-phase microextraction of phenol and chlorophenols from environmental samples.

Bagheri H, Aghakhani A, Baghernejad M, Akbarinejad A.

Anal Chim Acta. 2012 Feb 24;716:34-9. doi: 10.1016/j.aca.2011.03.016. Epub 2011 Mar 12.

PMID:
22284875
50.

Reinforced polydiphenylamine nanocomposite for microextraction in packed syringe of various pesticides.

Bagheri H, Ayazi Z, Es'haghi A, Aghakhani A.

J Chromatogr A. 2012 Jan 27;1222:13-21. doi: 10.1016/j.chroma.2011.11.063. Epub 2011 Dec 6.

PMID:
22204935

Supplemental Content

Loading ...
Support Center